![]() |
|
|
Vol. 283, Issue 1, 259-264, 1997
in Mice
Department of Clinical Pharmacokinetics, Division of Pharmaceutical
Science, Kyushu University, Fukuoka, Japan
The influence of dosing time on the pharmacological effects (fever and
antiviral activity) and the pharmacokinetics of interferon-
(IFN-
) was investigated in ICR male mice under light-dark (12:12) cycle. There was a significant circadian rhythm in rectal temperature, as an index of fever, at 0.5 hr after IFN-
(10.0 MIU/kg i.v.) injection. The rhythmic pattern resembled overall the rhythm that occurs in the nondrugged state. However, the percent change from basal
level of rectal temperature varied according to the dosing time. The
rhythmicity corresponded to the dosing time-dependent difference of
PGE2 levels in thalamus after IFN-
injection, but it did
not correspond to that of plasma IFN-
concentrations. A significant
dosing time-dependent difference was also demonstrated for
2
-5
oligoadenylate synthetase activities, as an index of antiviral
activity, in plasma and liver at 24 hr after IFN-
injection. It was
related to the rhythmicity in plasma IFN-
concentrations that was
caused by the rhythmicity in clearance of IFN-
. The choice of the
most appropriate time of day for drug administration may help to
achieve rational chronotherapeutics of IFN-
in certain experimental
and clinical situations.
This article has been cited by other articles:
![]() |
S. Koyanagi, H. Suyama, Y. Kuramoto, N. Matsunaga, H. Takane, S. Soeda, H. Shimeno, S. Higuchi, and S. Ohdo Glucocorticoid Regulation of 24-Hour Oscillation in Interferon Receptor Gene Expression in Mouse Liver Endocrinology, November 1, 2006; 147(11): 5034 - 5040. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Koyanagi, Y. Kuramoto, H. Nakagawa, H. Aramaki, S. Ohdo, S. Soeda, and H. Shimeno A Molecular Mechanism Regulating Circadian Expression of Vascular Endothelial Growth Factor in Tumor Cells Cancer Res., November 1, 2003; 63(21): 7277 - 7283. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Koyanagi, H. Nakagawa, Y. Kuramoto, S. Ohdo, S. Soeda, and H. Shimeno Optimizing the Dosing Schedule of TNP-470 [O-(Chloroacetyl-carbamoyl) Fumagillol] Enhances Its Antitumor and Antiangiogenic Efficacies J. Pharmacol. Exp. Ther., February 1, 2003; 304(2): 669 - 674. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Pan, T. Terada, M. Irie, H. Saito, and K.-I. Inui Diurnal rhythm of H+-peptide cotransporter in rat small intestine Am J Physiol Gastrointest Liver Physiol, July 1, 2002; 283(1): G57 - G64. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Viyoch, S. Ohdo, E. Yukawa, and S. Higuchi Dosing Time-Dependent Tolerance of Catalepsy by Repetitive Administration of Haloperidol in Mice J. Pharmacol. Exp. Ther., September 1, 2001; 298(3): 964 - 969. [Abstract] [Full Text] |
||||
![]() |
D.-s. Wang, S. Ohdo, S. Koyanagi, H. Takane, H. Aramaki, E. Yukawa, and S. Higuchi Effect of Dosing Schedule on Pharmacokinetics of Alpha Interferon and Anti-Alpha Interferon Neutralizing Antibody in Mice Antimicrob. Agents Chemother., January 1, 2001; 45(1): 176 - 180. [Abstract] [Full Text] |
||||
![]() |
S. Ohdo, D.-S. Wang, S. Koyanagi, H. Takane, K. Inoue, H. Aramaki, E. Yukawa, and S. Higuchi Basis for Dosing Time-Dependent Changes in the Antiviral Activity of Interferon-alpha in Mice J. Pharmacol. Exp. Ther., August 1, 2000; 294(2): 488 - 493. [Abstract] [Full Text] |
||||
![]() |
H. Takane, S. Ohdo, T. Yamada, E. Yukawa, and S. Higuchi Chronopharmacology of Antitumor Effect Induced by Interferon-beta in Tumor-Bearing Mice J. Pharmacol. Exp. Ther., August 1, 2000; 294(2): 746 - 752. [Abstract] [Full Text] |
||||